Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[Present and future of the transcranial magnetic stimulation].
Efficacy and safety of laquinimod in multiple sclerosis: current status.
Is there an association between the Expanded Disability Status Scale and inflammatory markers in multiple sclerosis?
Endogenous GABA controls oligodendrocyte lineage cell number, myelination, and CNS internode length.
Brain atrophy at onset and physical disability in multiple sclerosis.
A correlation study between multiple sclerosis and type 1 diabetes incidences and geochemical data in Europe.
Automatic segmentation of cerebral white matter hyperintensities using only 3D FLAIR images.
How compelling are the data for Epstein-Barr virus being a trigger for systemic lupus and other autoimmune diseases?
Examining multiple sclerosis through the eyes of a child.
NFAT1 deficit and NFAT2 deficit attenuate EAE via different mechanisms.
A systematic review and meta-analysis of strength training in individuals with multiple sclerosis or Parkinson disease.
Neuromyelitis optica spectrum disorder as a paraneoplastic manifestation of lung adenocarcinoma expressing aquaporin-4.
Natalizumab as a Disease-Modifying Therapy in Chronic Inflammatory Demyelinating Polyneuropathy - A Report of Three Cases.
Innovating openly: researchers and patients turn to crowdsourcing to collaborate on clinical trials, drug discovery, and more.
Partial acute transverse myelitis is a predictor of multiple sclerosis in children.
Magnetic resonance imaging in neuromyelitis optica.
Rebound of disease activity after withdrawal of fingolimod (FTY720) treatment.
Impairment of JCV-specific T-cell response by corticotherapy: Effect on PML-IRIS management?
Microsatellite polymorphism in haem oxygenase 1 gene promoter in multiple sclerosis.
[Efficacy and tolerability of long-term using of glatimer acetate (copaxone): a 10 year-study in the Moscow Municipal Multiple Sclerosis center.]
Activities-specific balance confidence in people with multiple sclerosis.
Elevated HSP27 levels during attacks in patients with multiple sclerosis.
Tertiary lymphoid organ development coincides with determinant spreading of the myelin-specific T cell response.
Brain leukocyte infiltration initiated by peripheral inflammation or experimental autoimmune encephalomyelitis occurs through pathways connected to the CSF-filled compartments of the forebrain and midbrain.
Helicobacter pylori serology in autoimmune diseases - fact or fiction?
Pages
« first
‹ previous
…
358
359
360
361
362
363
364
365
366
…
next ›
last »